HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo
about
Challenges and Opportunities for T-Cell-Mediated Strategies to Eliminate HIV ReservoirsHIV-1 functional cure: will the dream come true?T-cell therapies for HIVProliferation-linked apoptosis of adoptively transferred T cells after IL-15 administration in macaquesEngineering T Cells to Functionally Cure HIV-1 InfectionSingle DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individualsEradicating HIV-1 infection: seeking to clear a persistent pathogen.Broadly-specific cytotoxic T cells targeting multiple HIV antigens are expanded from HIV+ patients: implications for immunotherapy.Expanded cytotoxic T-cell lymphocytes target the latent HIV reservoirHIV-specific CD8⁺ T cells and HIV eradicationChimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving SuppresCell therapies for treatment of human immunodeficiency virus infection.Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections.Kill: boosting HIV-specific immune responses.T-cell therapies for HIV: Preclinical successes and current clinical strategies.Novel immunological strategies for HIV-1 eradicationHow Might We Cure HIV?Virus-Specific T Cells: Broadening Applicability.CRISPR therapeutic tools for complex genetic disorders and cancer (Review).HIV-Specific, Ex Vivo Expanded T Cell Therapy: Feasibility, Safety, and Efficacy in ART-Suppressed HIV-Infected IndividualsPhenotype, Polyfunctionality, and Antiviral Activity of Stimulated CD8 T-Cells From HIV Subjects Who Initiated cART at Different Time-Points After Acute Infection
P2860
Q26781511-199755C2-E624-44EE-AD77-71A96849E8B5Q26865803-E5F87435-7408-4F2B-97CF-3ED7CCB73FC7Q26866079-6C70D9F5-8B7A-4C0F-9A43-645DB7422AA9Q27314843-903F5451-7388-4A55-85B4-B456D9D24D54Q28086801-F10CB8DB-AC97-4C9F-894E-838753EB478EQ28730050-38731D97-DD4A-499E-9E11-9BEBE7AE625BQ35252186-41C0BDE7-E90D-486C-8494-D4DA8DABCA6DQ35653249-3BF9CB61-5E37-4A49-9715-08972466A060Q35812943-94A6CDAB-FC7C-47AB-A080-1A5E54A15112Q36515071-16119FC2-3404-4CDD-A88C-1CC2630D3D1CQ37347313-0A10BAA6-712F-42C7-A4F6-B9D942B98269Q38366376-F6FEAEDF-62FF-45F5-BDEA-97EAD0B5B29FQ38417056-A2672808-AB2B-4F77-9D40-9D5402394BDDQ38800533-F64F8B51-43A5-420B-9121-EE916A0716D9Q38856090-E796E7F3-178E-4086-AA58-1873E820009AQ38915896-F36F883E-2E9A-4E66-B315-B57335E278B2Q42227337-B36E533A-4FD4-4D29-8F37-9AF02E2C2C8FQ45326335-CF38CE91-9C99-4B8C-841D-414AA40585EEQ55383943-3BCF4A01-E585-4A3B-884E-85D65E9D23A5Q57039737-85359AC7-088F-4812-B86E-1D20B1BC9CB9Q58572549-BDE175E8-48BF-4491-BB0F-7AE47F59C26D
P2860
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivo
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@ast
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@en
type
label
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@ast
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@en
prefLabel
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@ast
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@en
P2093
P2860
P1433
P1476
HIV-specific CD8+ T cells from ...... c and mucosal immunity in vivo
@en
P2093
Aude G Chapuis
Cameron J Turtle
Corey Casper
Melinda L Cigal
Philip D Greenberg
Roxanne Velez
Stanley Riddell
Steve Kuntz
P2860
P304
P356
10.1182/BLOOD-2010-11-320226
P407
P577
2011-03-21T00:00:00Z